Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network 'Rete Ematologica del Lazio per i Linfomi' (RELLI).
Annibali O, Hohaus S, Marchesi F, Cantonetti M, Di Rocco A, Tomarchio V, Di Napoli A, Pelliccia S, Battistini R, Anticoli Borza P, Abruzzese E, Cenfra N, Andriani A, Tesei C, Alma E, Palombi F, Pupo L, Petrucci L, Becilli M, Maiolo E, Bellesi S, Cuccaro A, D'Alò F, Cox MC. Annibali O, et al. Among authors: pelliccia s. Leuk Lymphoma. 2019 Dec;60(14):3386-3394. doi: 10.1080/10428194.2019.1633628. Epub 2019 Jul 1. Leuk Lymphoma. 2019. PMID: 31259651
Tumor-associated and immunochemotherapy-dependent long-term alterations of the peripheral blood NK cell compartment in DLBCL patients.
Cox MC, Battella S, La Scaleia R, Pelliccia S, Di Napoli A, Porzia A, Cecere F, Alma E, Zingoni A, Mainiero F, Ruco L, Monarca B, Santoni A, Palmieri G. Cox MC, et al. Among authors: pelliccia s. Oncoimmunology. 2015 Jan 7;4(3):e990773. doi: 10.4161/2162402X.2014.990773. eCollection 2015 Mar. Oncoimmunology. 2015. PMID: 25949906 Free PMC article.
Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective Study.
DE Sanctis V, DI Rocco A, Cox MC, Valeriani M, Congedi FP, Anzellini D, Massaro M, Vullo G, Facondo G, DE Giacomo F, Alfò M, Prosperi D, Pizzichini P, Pelliccia S, Tafuri A, Martelli M, Osti MF. DE Sanctis V, et al. Among authors: pelliccia s. In Vivo. 2020 May-Jun;34(3):1407-1413. doi: 10.21873/invivo.11921. In Vivo. 2020. PMID: 32354938 Free PMC article.
All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma.
Cox MC, Banchi M, Pelliccia S, Di Napoli A, Marcheselli L, Patti C, Anticoli Borza P, Battistini R, Di Gregorio F, Orlandi P, Bocci G. Cox MC, et al. Among authors: pelliccia s. Cancer Chemother Pharmacol. 2020 Dec;86(6):841-846. doi: 10.1007/s00280-020-04172-3. Epub 2020 Oct 18. Cancer Chemother Pharmacol. 2020. PMID: 33070248 Free PMC article.
Angioimmunoblastic T-Cell Lymphoma with Exuberant CD30-Positive Follicular Dendritic Cell Proliferation in a SARS-CoV-2 Patient: The Role of Mutational Analysis to Exclude an Associated Follicular Dendritic Cell Sarcoma.
Rogges E, Pelliccia S, Lopez G, Barresi S, Tafuri A, Alaggio R, Di Napoli A. Rogges E, et al. Among authors: pelliccia s. Int J Mol Sci. 2022 Aug 19;23(16):9349. doi: 10.3390/ijms23169349. Int J Mol Sci. 2022. PMID: 36012614 Free PMC article.
IgM-secreting diffuse large B-cell lymphoma: results of a multicentre clinicopathological and molecular study.
Cox MC, Marcheselli L, Scafetta G, Visco C, Hohaus S, Annibali O, Musuraca G, Fabbri A, Cantonetti M, Pelliccia S, Papotti R, Petrucci L, Tani M, Battistini R, Arcari A, Luminari S, Lopez G, Alma E, Pupo L, Carli G, Marchesi F, Re F, Scarpino S, D'amore ESG, Larocca LM, Bianchi A, Pepe G, Natalino F, Anticoli-Borza P, Cenfra N, Andriani A, Abruzzese E, Tesei C, Leoncini L, Asioli S, Ruco L, Di Napoli A. Cox MC, et al. Among authors: pelliccia s. Leukemia. 2022 Nov;36(11):2719-2723. doi: 10.1038/s41375-022-01706-x. Epub 2022 Sep 20. Leukemia. 2022. PMID: 36127510 No abstract available.
62 results